Clostridioides difficile Infection in Chronic Kidney Disease/End-Stage Renal Disease.

Related Articles

Clostridioides difficile Infection in Chronic Kidney Disease/End-Stage Renal Disease.

Adv Chronic Kidney Dis. 2019 Jan;26(1):30-34

Authors: Ramesh MS, Yee J

Abstract
Clostridioides difficile infection (CDI) is a major health-care burden and increasingly seen in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Increased antibiotic use, alteration in host defenses, and gastric acid suppression are some of the etiologies for increased risk of CDI in these populations. Patients with CKD/ESRD have a higher risk of initial episode, recurrence, and development of severe CDI than those without CKD or ESRD. Diagnosis and management of CDI in patients with CKD/ESRD are similar to that in the general population. The mortality, length of stay, and health-care costs are higher in patients with CDI and CKD/ESRD. Antimicrobial stewardship with reduction in antibiotic use along with infection-control measures such as contact isolation and hand hygiene with soap and water is essential in the control and prevention of CDI in patients with CKD/ESRD.

PMID: 30876614 [PubMed - in process]